Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 217

1.

Breadth of the HCV-specific CD4+ T-cell response in spontaneous resolvers is independent of the IL-28 haplotype.

Scheurich C, Schulze Zur Wiesch J, Kim AY, Lewis-Ximenez L, Meyer T, Polywka S, Chung RT, Lauer GM.

J Viral Hepat. 2016 Jun 27. doi: 10.1111/jvh.12560. [Epub ahead of print] No abstract available.

PMID:
27346754
2.

Contour identical implants to bridge mandibular continuity defects--individually generated by LaserCUSING®--A feasibility study in animal cadavers.

Reitemeier B, Schöne C, Lesche R, Lauer G, Schulz MC, Markwardt J.

Head Face Med. 2016 Apr 11;12:17. doi: 10.1186/s13005-016-0114-0.

3.

Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative.

Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH.

Open Forum Infect Dis. 2016 Feb 8;3(1):ofw024. doi: 10.1093/ofid/ofw024. eCollection 2016 Jan.

4.

Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16.

Gunn BM, Schneider JR, Shansab M, Bastian AR, Fahrbach KM, Smith AD 4th, Mahan AE, Karim MM, Licht AF, Zvonar I, Tedesco J, Anderson MR, Chapel A, Suscovich TJ, Malaspina DC, Streeck H, Walker BD, Kim A, Lauer G, Altfeld M, Pillai S, Szleifer I, Kelleher NL, Kiser PF, Hope TJ, Alter G.

Mucosal Immunol. 2016 Mar 9. doi: 10.1038/mi.2016.8. [Epub ahead of print]

PMID:
26960182
5.

CD39 Expression Identifies Terminally Exhausted CD8+ T Cells.

Gupta PK, Godec J, Wolski D, Adland E, Yates K, Pauken KE, Cosgrove C, Ledderose C, Junger WG, Robson SC, Wherry EJ, Alter G, Goulder PJ, Klenerman P, Sharpe AH, Lauer GM, Haining WN.

PLoS Pathog. 2015 Oct 20;11(10):e1005177. doi: 10.1371/journal.ppat.1005177. eCollection 2015 Oct.

6.

Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.

Walker A, Skibbe K, Steinmann E, Pfaender S, Kuntzen T, Megger DA, Groten S, Sitek B, Lauer GM, Kim AY, Pietschmann T, Allen TM, Timm J.

J Virol. 2015 Oct 7;90(1):33-42. doi: 10.1128/JVI.01993-15.

7.

The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease.

Simon TG, Kim AY, Stamm LM, Liu L, Mo H, Doehle B, Pang PS, Brainard DM, McHutchison JG, Gustafson J, Lauer GM, Chung RT.

Antivir Ther. 2015 Oct 6. doi: 10.3851/IMP2997. [Epub ahead of print]

PMID:
26440471
8.

Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review.

Onofrey S, Aneja J, Haney GA, Nagami EH, DeMaria A Jr, Lauer GM, Hills-Evans K, Barton K, Kulaga S, Bowen MJ, Cocoros N, McGovern BH, Church DR, Kim AY.

Ann Intern Med. 2015 Aug 18;163(4):254-61. doi: 10.7326/M14-2939.

9.

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.

von Delft A, Humphreys IS, Brown A, Pfafferott K, Lucas M, Klenerman P, Lauer GM, Cox AL, Gaudieri S, Barnes E.

Gut. 2016 Jan;65(1):112-23. doi: 10.1136/gutjnl-2014-308724. Epub 2015 Jun 19.

10.

The current state of facial prosthetics – A multicenter analysis.

Thiele OC, Brom J, Dunsche A, Ehrenfeld M, Federspil P, Frerich B, Hölzle F, Klein M, Kreppel M, Kübler AC, Kübler NR, Kunkel M, Kuttenberger J, Lauer G, Mayer B, Mohr C, Neff A, Rasse M, Reich RH, Reinert S, Rothamel D, Sader R, Schliephake H, Schmelzeisen R, Schramm A, Sieg P, Terheyden H, Wiltfang J, Ziegler CM, Mischkowski RA, Zöller JE.

J Craniomaxillofac Surg. 2015 Sep;43(7):1038-41. doi: 10.1016/j.jcms.2015.04.024. Epub 2015 May 15.

PMID:
26054445
11.

Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study.

Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M; InC3 study group.

J Infect Dis. 2015 Nov 1;212(9):1407-19. doi: 10.1093/infdis/jiv220. Epub 2015 Apr 15.

PMID:
25883387
12.

[Bisphosphonate-associated osteonecrosis of the jaw].

Koy S, Schubert M, Koy J, Ney M, Lauer G, Sabatowski R.

Schmerz. 2015 Apr;29(2):171-8. doi: 10.1007/s00482-014-1499-y. German.

PMID:
25860198
13.

Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.

Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Dore GJ, Grebely J; InC3 Study Group.

PLoS One. 2015 Apr 2;10(4):e0122232. doi: 10.1371/journal.pone.0122232. eCollection 2015.

14.

Autogenous bone and a bovine bone substitute for ridge preservation - preliminary clinical and histologic findings.

Schulz MC, Kallweit MB, Kallweit S, Koch R, Lauer G, Mai R, Hoffmann T.

Aust Dent J. 2015 Mar 26. doi: 10.1111/adj.12313. [Epub ahead of print]

PMID:
25819677
15.

A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.

Spelman T, Morris MD, Zang G, Rice T, Page K, Maher L, Lloyd A, Grebely J, Dore GJ, Kim AY, Shoukry NH, Hellard M, Bruneau J; International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3 Study).

J Epidemiol Community Health. 2015 Aug;69(8):745-52. doi: 10.1136/jech-2014-205224. Epub 2015 Mar 26.

16.

Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study.

Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J; InC3 Study Group.

J Viral Hepat. 2015 Sep;22(9):708-17. doi: 10.1111/jvh.12384. Epub 2015 Jan 8.

PMID:
25580520
17.

Multi-analyte profiling of inflammatory mediators in COPD sputum--the effects of processing.

Pedersen F, Holz O, Lauer G, Quintini G, Kiwull-Schöne H, Kirsten AM, Magnussen H, Rabe KF, Goldmann T, Watz H.

Cytokine. 2015 Feb;71(2):401-4. doi: 10.1016/j.cyto.2014.10.008. Epub 2014 Nov 15.

PMID:
25464927
18.

A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.

Baumert TF, Fauvelle C, Chen DY, Lauer GM.

J Hepatol. 2014 Nov;61(1 Suppl):S34-44. doi: 10.1016/j.jhep.2014.09.009. Epub 2014 Nov 3. Review.

19.

Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study.

Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J; InC(3)Study Group.

J Clin Virol. 2014 Nov;61(3):430-4. doi: 10.1016/j.jcv.2014.08.027. Epub 2014 Sep 8.

20.

Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.

Cosgrove C, Berger CT, Kroy DC, Cheney PC, Ghebremichael M, Aneja J, Tomlinson M, Kim AY, Lauer GM, Alter G.

PLoS One. 2014 Aug 22;9(8):e105950. doi: 10.1371/journal.pone.0105950. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk